|
1
|
Gilad S, Chessa L, Khosravi R, Russell P,
Galanty Y, Piane M, Gatti RA, Jorgensen TJ, Shiloh Y and Bar-Shira
A: Genotype-phenotype relationships in ataxia-telangiectasia and
variants. Am J Hum Genet. 62:551–561. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schoenaker MH, Suarez F, Szczepanski T,
Mahlaoui N and Loeffen JL: Treatment of acute leukemia in children
with ataxia telangiectasia (A-T). Eur J Med Genet. 59:641–646.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
National Cancer Institute. Ataxia
telangiectasia, . Fact sheet. https://www.cancer.gov/about-cancer/causes-prevention/genetics/ataxia-fact-sheetDecember
18–2018
|
|
4
|
Chun HH and Gatti RA:
Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst).
3:1187–1196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tavani F, Zimmerman RA, Berry GT, Sullivan
K, Gatti R and Bingham P: Ataxia-telangiectasia: The pattern of
cerebellar atrophy on MRI. Neuroradiology. 45:315–319. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Waldmann TA and McIntire KR:
Serum-alpha-fetoprotein levels in patients with
ataxia-telangiectasia. Lancet. 2:1112–1115. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jason JM and Gelfand EW: Diagnostic
considerations in ataxia-telangiectasia. Arch Dis Child.
54:682–686. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gatti RA, Berkel I, Boder E, Braedt G,
Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NG, Lange K, et
al: Localization of an ataxia-telangiectasia gene to chromosome
11q22-23. Nature. 336:577–580. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chun HH, Sun X, Nahas SA, Teraoka S, Lai
CH, Concannon P and Gatti RA: Improved diagnostic testing for
ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM
protein expression. Mol Genet Metab. 80:437–443. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu Y, Gao P, Lv X, Zhang L and Zhang J:
The role of the ataxia telangiectasia mutated gene in lung cancer:
Recent advances in research. Ther Adv Respir Dis. 11:375–380. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goodarzi AA, Jonnalagadda JC, Douglas P,
Young D, Ye R, Moorhead GB, Lees-Miller SP and Khanna KK:
Autophosphorylation of ataxia-telangiectasia mutated is regulated
by protein phosphatase 2A. EMBO J. 23:4451–4461. 2014. View Article : Google Scholar
|
|
12
|
Kozlov SV, Graham ME, Jakob B, Tobias F,
Kijas AW, Tanuji M, Chen P, Robinson PJ, Taucher-Scholz G, Suzuki
K, et al: Autophosphorylation and ATM activation: Additional sites
add to the complexity. J Biol Chem. 286:9107–9119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barlow C, Dennery PA, Shigenaga MK, Smith
MA, Morrow JD, Roberts LJ II, Wynshaw-Boris A and Levine RL: Loss
of the ataxia-telangiectasia gene product causes oxidative damage
in target organs. Proc Natl Acad Sci USA. 96:9915–9919. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan M, Qiang W, Liu N, Shen J, Lynn WS and
Wong PK: The ataxia-telangiectasia gene product may modulate DNA
turnover and control cell fate by regulating cellular redox in
lymphocytes. FASEB J. 15:1132–1138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan M, Zhu C, Liu N, Jiang Y, Scofield VL,
Riggs PK, Qiang W, Lynn WS and Wong PK: ATM controls c-Myc and DNA
synthesis during postnatal thymocyte development through regulation
of redox state. Free Radic Biol Med. 41:640–648. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsuoka S, Ballif BA, Smogorzewska A,
McDonald ER III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini
N, Lerenthal Y, et al: ATM and ATR substrate analysis reveals
extensive protein networks responsive to DNA damage. Science.
316:1160–1166. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Medical Research Council, . Aids to
examination of the peripheral nervous system. Memorandum No. 45.
Medical Research Council; London: 1976
|
|
18
|
Cornblath D: Electrophysiology in
Guillain-Barre syndrome. Ann Neurol. 27 (Suppl):S17–S20. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou X, Liao Y, Xu M, Ji Z, Xu Y, Zhou L,
Wei X, Hu P, Han P, Yang F, et al: A novel mutation R190H in the
AT-hook 1 domain of MeCP2 identified in an atypical Rett syndrome.
Oncotarget. 8:82156–82164. 2017.PubMed/NCBI
|
|
20
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the american college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei X, Ju X, Yi X, Zhu Q, Qu N, Liu T,
Chen Y, Jiang H, Yang G, Zhen R, et al: Identification of sequence
variants in genetic disease-causing genes using targeted
next-generation sequencing. PLoS One. 6:e295002013. View Article : Google Scholar
|
|
22
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumar P, Henikoff S and Ng PC: Predicting
the effects of coding non-synonymous variants on protein function
using the SIFT algorithm. Nat Protoc. 4:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moulton J: Functional characterization and
targeted correction of ATM mutations identified in Japanese
patients with ataxia-telangiectasia. Hum Mutat. 33:198–208.
2015.
|
|
25
|
Teraoka SN, Telatar M, Becker-Catania S,
Liang T, Onengüt S, Tolun A, Chessa L, Sanal O, Bernatowska E,
Gatti RA and Concannon P: Splicing defects in the
ataxia-telangiectasia gene, ATM: Underlying mutations and
consequences. Am J Hum Genet. 64:1617–1631. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buzin CH, Gatti RA, Nguyen VQ, Wen CY,
Mitui M, Sanal O, Chen JS, Nozari G, Mengos A, Li X, Fujimura F and
Sommer SS: Comprehensive scanning of the ATM gene with DOVAM-S. Hum
Mutat. 21:123–131. 2010. View Article : Google Scholar
|
|
27
|
Lavin MF and Shiloh Y: The genetic defect
in ataxia-telangiectasia. Ann Rev Immunol. 15:177–202. 2003.
View Article : Google Scholar
|
|
28
|
Taylor AM, Byrd PJ, McConville CM and
Thacker S: Genetic and cellular features of ataxia telangiectasia.
Int J Radiat Biol. 65:65–70. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kraus M, Lev A, Simon AJ, Levran I,
Nissenkorn A, Levi YB, Berkun Y, Efrati O, Amariglio N, Rechavi G
and Somech R: Disturbed B and T cell homeostasis and neogenesis in
patients with ataxia telangiectasia. J Clin Immunol. 34:561–572.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wright J, Teraoka S, Onengut S, Tolun A,
Gatti RA, Ochs HD and Concannon P: A high frequency of distinct ATM
gene mutations in ataxia-telangiectasia. Am J Hum Genet.
59:839–846. 1996.PubMed/NCBI
|
|
31
|
Concannon P and Gatti RA: Diversity of ATM
gene mutations detected in patients with ataxia-telangiectasia. Hum
Mutat. 10:100–107. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li A and Swift M: Mutations at the
ataxia-telangiectasia locus and clinical phenotypes of A-T
patients. Am J Med Genet. 92:170–177. 2010. View Article : Google Scholar
|
|
33
|
Jacquemin V, Rieunier G, Jacob S,
Bellanger D, d'Enghien CD, Laugé A, Stoppa-Lyonnet D and Stern MH:
Underexpression and abnormal localization of ATM products in ataxia
telangiectasia patients bearing ATM missense mutations. Eur J Hum
Genet. 20:305–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
